Researchers conducted a case-control study to determine whether colonoscopy is associated with decreased CRC mortality in veterans and whether its effect differs by anatomical location of CRC.
1. Colonoscopy in veterans was associated with reduced mortality from both left and right-sided colorectal cancer. 2. Mortality was reduced by 61% in patients screened by colonoscopy. Evidence Rating Level: 2 (Good) Study Rundown: Colorectal cancer (CRC) screening serves as a critical element of CRC prevention and management. To date, colonoscopy remains the gold standard 
An analysis of 23 studies focused on interventions with the potential to improve follow-up colonoscopy completion rates found that navigation programs are more effective than other interventions studied.
Investigators sought to determine clinical and cost effectiveness of additional colonoscopy screening in patients undergoing FIT screening for colorectal cancer.
This study investigated the impact of exercise (1 hour/week) and low body fat mass on recurrence of colorectal polyp recurrence among survivors of colorectal cancer.
The United States Multi-Society Task Force (MSTF) on Colorectal Cancer Screening updated its recommendations, confirming that screening in people at average risk should begin at age 50 years. The update also includes a ranking of current screening modalities.
Risk for Disease, Advanced Stage at Diagnosis Higher With Delayed Colonoscopy After Positive FIT ResultsMay 12, 2017
Waiting 10 months or longer before follow-up colonoscopy after a positive FIT result is associated with higher risk of disease as well as advanced stage at diagnosis.
Patients' confidence with colorectal cancer screening procedures is predictive of their likelihood to schedule and follow through with screening.
An assessment of the use of mammography and colonoscopy among fee-for-service Medicare beneficiaries before and after the Affordable Care Act demonstrates the impact of out-of-pocket costs in this population.
Survey data from patients receiving care at Boston Medical Center who were navigated for colonoscopy screening illustrates how patients value the services of oncology patient navigators.
Novel preparation formulation is as effective and safe as current colon prep for colonoscopy. Plus, study participants gave the prep experience a high satisfaction rating.
Screening for colorectal cancer (CRC) is not widely used by Americans age 75 years and older, even though some patients are healthy and may benefit.
Offering free screening colonoscopies can identify CRC earlier in uninsured patients who are at high risk for developing the disease. In addition, the program is cost neutral from the perspective of a hospital system.
The time between a positive fecal blood test result for colon cancer screening and a follow-up colonoscopy varies widely across the United States.
The generally low risk of colonoscopy and the widely accepted guidelines for polyp surveillance and colon cancer screening may render precolonoscopy gastroenterology office visits unnecessary.
Fifteen variables independently associated with measure; shows variation in quality among facilities
A new risk assessment scoring system could help physicians determine which patients can forgo invasive colonoscopy for cancer screening and which patients should undergo the procedure.
Having patients lie on their left side while examining the right side of their colon during a colonoscopy can result in more polyps being found, thus increasing the effectiveness of the screening technique.
A clinical scoring system for colon cancer risk could help physicians determine which patients require colonoscopies and which could be adequately screened using less invasive methods.
Patients with colorectal cancer that is detected during a colonoscopy screening are more likely to survive to longer than patients who are not diagnosed until they have symptoms.
Higher adenoma detection rates may be associated with much lower lifetime colorectal cancer incidence and death without higher overall costs, research indicates.
Higher-quality colonoscopies, which need not be more expensive, are linked to lower colorectal cancer risk.
Higher adenoma detection rates from colonoscopy screenings may be associated with a lower lifetime colorectal cancer incidence.
A new noninvasive technology for colon cancer screening could prove promising for African-Americans, a group at higher than average risk of colon cancer.
In an average-risk screening population, capsule colonoscopy seems adequate for patients who cannot undergo colonoscopy or who had incomplete colonoscopies.
A recent study examined why individuals do not always follow through with colorectal cancer screening.
A new study indicates that raising the colorectal cancer screening rates to 80% by 2018 could prevent an additional 21,000 colorectal cancer deaths per year by 2030.
Annual FIT IDs all colorectal cancer, and may be equivalent to colonoscopy in detecting advanced neoplasia in first-degree relatives of patients with colorectal cancer (CRC).
A retrospective study has uncovered an overuse of colonoscopies for colorectal cancer screening and surveillance.
For the group deemed at high risk of developing colorectal cancer, fecal blood tests appear to be a more effective means of screening than colonoscopy.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
- Drug Classification of Trastuzumab
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|